Patents
Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
01/2007
01/03/2007CN1293060C Substituted aryl sulphonyl(thio)ureas used as herbicides
01/03/2007CN1293056C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
01/02/2007CA2274464C Ketobenzamides as calpain inhibitors
12/2006
12/27/2006EP1299374B1 Novel non-psychotropic cannabinoids
12/27/2006CN1291985C Neurotrophin production/secretion promoting agent
12/26/2006US7153974 Heat and corrosion resistance
12/26/2006US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
12/21/2006US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/20/2006EP1734041A2 Platelet ADP receptor inhibitors
12/20/2006EP1456171B1 Substituted cyclohexane derivatives
12/20/2006EP0794946B1 Alkylidenehydrazinophenylsulphonyl ureas, methods of preparing them and their use as herbicides and plant-growth regulators
12/19/2006US7151182 Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives
12/19/2006US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006CA2239805C Stabilized hydroxylamine solutions
12/14/2006DE102005025315A1 Ionische Flüssigkeiten mit niedriger Viskosität Ionic liquids with low viscosity
12/13/2006EP1392676B1 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands
12/13/2006EP0738260B2 Pesticides
12/13/2006CN1878552A Methods of use of thrombin receptor antagonists
12/13/2006CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/12/2006CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine
12/06/2006EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/05/2006US7145004 Treating a perfluoroalkylphosphorane with an alkaline earth metal hydroxide, an organometallic compound, or an organic base, and optionally treating with an acid in a reaction medium; use as ionic liquids, surfactants or phase-transfer catalysts
12/05/2006US7144899 Thrombin inhibitors
12/05/2006US7144897 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
12/05/2006US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
11/2006
11/30/2006US20060270712 contains 4-[ alpha -hydroxy-5-(1-imidazolyl)-2-methylbenzyl]-3,5-dimethylbenzoic acid; prophylaxis, hypomyelination, dysmyelination or demyelination; myelin-associated glycoprotein (MAG)
11/29/2006EP0971854B1 Novel materials useful as electrolytic solutes
11/29/2006CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/28/2006US7141595 Amino benzothiazole compounds with NOS inhibitory activity
11/28/2006US7141583 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/28/2006US7141580 activity as prostaglandin E2 receptor antagonists
11/23/2006US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006US20060264626 INHIBITORS OF FACTOR Xa AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE
11/23/2006US20060264430 Pyrazole derivative
11/22/2006EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006CN1285588C Farnesyl protein transferase inhibitors
11/22/2006CN1285579C Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same
11/21/2006US7138432 Arylsulfonamido-substituted hydroxamic acid derivatives
11/21/2006US7138414 Antidiabetic agents
11/21/2006US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006US7138393 Biologically active vasopressin agonist metabolites
11/16/2006US20060258728 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
11/16/2006US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/15/2006EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006CN1863891A Organic compound and organic light emitting device using the same
11/15/2006CN1863777A Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
11/15/2006CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/14/2006US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006US20060252795 Chemokine receptor binding heterocyclic compounds
11/08/2006EP1303514B9 Process for preparing azacycloalkanoylaminothiazoles
11/07/2006US7132543 Para-phenylenediamine derivatives containing a disubstituted pyrrolidinyl group bearing a cationic radical, and use of the same for dyeing keratin fibers
11/07/2006US7132457 Adamantane derivatives
11/07/2006US7132438 Benzimidazole derivatives
11/07/2006US7132437 for example, methyl 4'-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl][1,1'-biphenyl]-2-carboxylate; for treatment of congestive heart failure
11/07/2006US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006US20060247210 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
11/02/2006EP1585744B1 Process for making ondansetron and intermediates thereof
11/02/2006EP1539747B1 N-aroyl cyclic amines as orexin receptor antagonists
11/02/2006EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/01/2006CN1282642C Intermediates for preparing aminophenylsulfonylureas and preparation method therefor
10/2006
10/31/2006US7129261 Cytotoxic agents
10/31/2006US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006US7129238 such as (S)-N-(4-Carbamimidoyl-benzyl)-2-methoxy-2-phenyl-acetamide hydrochloride, for inhibiting formation of coagulation factors Xa, IXa and thrombin induced by factor VIIa and tissue factor
10/31/2006CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/26/2006US20060241153 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide; potent and highly selective inhibitors; coagulation disorders; antithrombotic agents; diagnostic reagents; good bioavailability and/or solubility
10/26/2006US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
10/25/2006CN1281604C Substituted pyrazole compounds
10/24/2006US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006US7126007 Reproducible; avoids use of 3-pyrrolidinol as a starting material
10/24/2006US7126001 Antiproliferative agents; antitumor agents
10/24/2006US7125995 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS)
10/24/2006US7125905 Pyrrole substituted 2-indolinone protein kinase inhibitors
10/24/2006US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
10/19/2006US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006US20060235021 Phenylpyridazine derivatives as ligands for gaba receptors
10/18/2006EP1711472A1 Mehtod for producing ionic liquids
10/17/2006US7121707 Illuminated electrical cords and outlets
10/17/2006CA2241856C Agent for prophylaxis and treatment of diabetic complications
10/17/2006CA2212888C A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
10/12/2006DE102005016344A1 Verfahren zur Herstellung von Diarylbenzidinen A process for preparing Diarylbenzidinen
10/11/2006EP1710231A1 CETP activity inhibitors
10/11/2006EP1708976A1 Distillation of ionic liquids
10/11/2006EP1363903B1 Indole derivatives and their use as gnrh antagonists
10/11/2006EP1309561B1 1h-pyrazol derivatives, method for producing them and their use as nitrification inhibitors
10/10/2006CA2262617C Nitrification inhibitors and the use of polyacids to treat mineral fertilizers containing a nitrification inhibitor
10/10/2006CA2248068C Substituted aryl sulphonyl(thio)ureas used as herbicides
10/04/2006EP1406900B1 Novel compounds, their preparation and use
10/04/2006CN1277829C 3, 5-disubstituted-oxazolidine with antibiotic activity, its preparation method and use
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 163